Heart Test Laboratories, Inc. received a staff determination from Nasdaq to delist the company's securities from the Nasdaq Capital Market due to the closing bid price of the common stock being $0.10 or less for at least ten consecutive trading days. The company intends to appeal the staff determination and implement a reverse stock split to regain compliance.